Fluid Guided Heart Failure Treatment at the Cleveland Clinic
Recruiting · NCT07205120 · Interventional (participants receive a specific treatment) · Lead sponsor: Bodyport Inc.
View the official record on ClinicalTrials.gov →Interventions studied
Heart Failure Management Intervention
What this trial is about
FIGHT-HF is an exploratory non-randomized open-label study evaluating a heart failure management intervention. The goal of this pilot is to assess the performance of a fluid-guided heart failure management program and Alert Response Guide (ARG) using the Bodyport Cardiac Scale and Congestion Index in 50 adult participants with acute and chronic heart failure, who are followed by a Cleveland Clinic cardiologist.
Who can take part
Age range
21 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Hospitalized for acute decompensated heart failure
- Age 21 years or older
- Able to speak and read English
Exclusion criteria
- New York Heart Association functional class IV symptoms
- Received or are scheduled to receive a heart transplant or ventricular assist - device in the next 12 months
- Have a glomerular filtration rate of less than 25 mL/min while nonresponsive to diuretic therapy or on chronic renal dialysis
- Have a history of regularly scheduled intravenous HF therapy (e.g., inotropes or diuretics)
- Have a life expectancy of less than 12 months
- Are pregnant or plan to become pregnant during the next 12 months
- Weigh greater than 375 lbs
- Unable to stand on two bare feet without assistance
Where it is running
1 location listed across 1 US state.
- The Cleveland Clinic - Cleveland, Ohio, United States